About: Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 03 January 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 2007 (uk) article scientifique publié en 2007 (fr) artículu científicu espublizáu en xineru de 2007 (ast) scientific article published on 03 January 2007 (en)
publication date	wds:Q79484933-6F47F9BA-5295-4056-BD92-AE76FA5B84CC
publication date	2007-01-03 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q79484933-90DC6341-BAA4-4700-9B98-B1CF0BC6B503
language of work or name	English
cites work	wds:Q79484933-401659B2-842F-4AE1-88D2-0FB86AADA8D8
cites work	Mutant PIK3CA promotes cell growth and invasion of human cancer cells
author name string	wds:Q79484933-04858564-15C1-4656-B2F5-686F9BEF23BF wds:Q79484933-3E4166FE-6344-46B9-A5A2-F5B7756A9579 wds:Q79484933-5CB5976E-AB6A-4E25-98EE-6F067B62DAAF wds:Q79484933-8FEAD6A4-AE94-4C66-80DD-5D9662863DA9 wds:Q79484933-A68EC011-5FE4-4E10-8E12-CC741D53ED61 wds:Q79484933-A9AB6F64-DC74-45D0-A05B-679312041947
author name string	Morito Monden Shinzaburo Noguchi Tetsuya Taguchi Yasuo Miyoshi Yasuhiro Tamaki Naomi Maruyama
rdfs:label	Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (en) Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (nl)
skos:prefLabel	Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (en) Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (nl)
name	Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (en) Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (nl)
title	wds:Q79484933-1D702E9C-6616-4D16-BF50-2328CDFC51FE
title	Clinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese women (en)
page(s)	wds:Q79484933-06B676CB-25F3-4504-91F0-096DA9CD190B
page(s)	408-414
instance of	wds:Q79484933-613ACF47-9558-4EFB-9FBD-57FE7CEADF15
instance of	scholarly article
PubMed ID	wds:Q79484933-F3683B05-4A84-4CB8-A7C8-F0F66B271C07
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17202311
PubMed ID	17202311
published in	wds:Q79484933-CDFAC93F-1D92-4FC0-8DC3-182CBE723AF4
published in	Clinical Cancer Research
issue	wds:Q79484933-279A323E-6290-4F2E-ADD5-29AB62453651
volume	wds:Q79484933-B6C0EC41-260C-469E-8AAC-BF4EC82F5021
issue	2 Pt 1
volume	13
DOI	wds:Q79484933-3FE6A91B-0339-4AD8-AC44-BA6F45DE6725
DOI	http://dx.doi.org/10.1158/1078-0432.CCR-06-0267
DOI	10.1158/1078-0432.CCR-06-0267
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79484933
is cites work of	PIK3R1 underexpression is an independent prognostic marker in breast cancer PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas. PIK3CA alterations in Middle Eastern ovarian cancers Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy? Membrane lipids in invadopodia and podosomes: key structures for cancer invasion and metastasis The molecular background of mucinous carcinoma beyond MUC2 Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer Phosphoinositide 3-kinase signaling pathway mediated by p110α regulates invadopodia formation Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib PI3K mutations in breast cancer: prognostic and therapeutic implications Prognostic role of PIK3CA mutations and their association with hormone receptor expression in breast cancer: a meta-analysis PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients PI3KCA mutation status is of limited prognostic relevance in ER-positive breast cancer patients treated with hormone therapy. Evaluation of PTEN loss and PIK3CA mutations and their correlation with efficacy of trastuzumab treatment in HER2-positive metastatic breast cancer: A retrospective study (KBC-SG 1001) PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer. Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancer The favorable impact of PIK3CA mutations on survival: an analysis of 2587 patients with breast cancer Oncogenic PIK3CA mutations in lobular breast cancer progression. PIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy. Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review The PIK3CA gene as a mutated target for cancer therapy Lack of evidence for KRAS oncogenic mutations in triple-negative breast cancer Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients. Oncogenic mutations of PIK3CA in human cancers PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients PIK3CA mutations define favorable prognostic biomarkers in operable breast cancer: a systematic review and meta-analysis Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial. Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer. Prognostic and Predictive Biomarkers of Endocrine Responsiveness for Estrogen Receptor Positive Breast Cancer Correlation between activation of PI3K/AKT/mTOR pathway and prognosis of breast cancer in Chinese women Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients. PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses. Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials. Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer. Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer. Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 176 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software